comparemela.com

Latest Breaking News On - Bionano saphyr - Page 7 : comparemela.com

Global Market For Sleep Aid Devices Could Reach $112 7 Billion By 2025

Share this article Share this article PALM BEACH, Fla., April 23, 2021 /PRNewswire/ Sleep is an essential need of all species… including homo sapiens, especially now during the pandemic. Sleep disorders are affecting a large pool of population, which has boosted the awareness about these disorders and other related ailments. Increase in the prevalence of sleep disorders has led to an expansion of private care centers and hospitals. These sleep centers have increased awareness among people about the importance of tracking sleep patterns for better sleep. This is driving the usage of home sleep screening devices for sleep disorder cases, and subsequently increasing the revenue generation of the home sleep screening devices market. Various reports project that the market for sleep aides or technical devices should continue to grow for at least the next several years. One such report from Zion marketing (discussed in IPS News) said that the global demand for Sleep Tech Devices M

BNGO stock price: Bionano Genomics Inc runs into technical resistance, put options may work here

BNGO stock price: Bionano Genomics Inc runs into technical resistance, put options may work here
fxstreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fxstreet.com Daily Mail and Mail on Sunday newspapers.

BNGO Stock Forecast: BioNano Genomics gains on Saphyr adoption in U K labs

BNGO Stock Forecast: BioNano Genomics jumps by nearly 10% on Saphyr adoption in U.K. labsNEWS | 4/22/2021 2:09:00 PM GMT | By Stocks Reporter NASDAQ:BNGO added 9.85% on Wednesday as the broader markets enjoyed a rare day in the green. BioNano’s Saphyr system has been adopted by two major labs in the U.K. which are owned by NHS. BNGO is ramping up its development as it plans to release the prototype for its next generation of Saphyr later this year. Update April 24: BioNano Genomics Inc (NASDAQ: BNGO) shares have kicked off Thursday s session with an increase of nearly 10% to around $6.50. As detailed below, the gene-related company is venturing into the British market and that provides fresh prospects for higher incomes. The gains recorded on Thursday complete a third consecutive day of gains after BNGO shares lost ground throughout most of April. 

Should You Buy Bionano Genomics in April?

This stock market mover's growth story is just beginning.

Bionano Genomics Announces Presentations on Optical Genome Mapping at the American Association for Cancer Research (AACR) Annual Meeting 2021

Session Category: Molecular and Cellular Biology/Genetics Session Title: Genomic Profiling of Tumors Permanent Abstract Number: 2234 Authors: Xiaobo Chen, Huan Tian, Wubin Qian, Henry Q. Li, Sheng Guo. Crown Bioscience Inc, Suzhou, China, Crown Bioscience Inc, San Diego, CA About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument,

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.